Market Overview
Elastography imaging encompasses technologies such as shear wave elastography and strain imaging, commonly integrated with ultrasound and MRI systems. The technology is widely adopted in radiology and hepatology for assessing liver fibrosis, as well as in oncology and cardiology for characterizing tissue properties. Its non-invasive nature reduces patient discomfort and procedural costs compared to traditional biopsy methods.
- •Modalities include Ultrasound Elastography and Magnetic Resonance Elastography (MRE)
- •Primary applications span radiology, hepatology, cardiology, and obstetrics
- •Technique types include shear wave elastography, transient elastography, and strain imaging
Growth Drivers
The global burden of chronic liver diseases, including non-alcoholic fatty liver disease (NAFLD) and hepatitis, is driving demand for early, accurate, and non-invasive diagnostics. Additionally, advancements in imaging resolution and integration with AI-assisted analysis are making elastography more accessible and clinically valuable. Healthcare systems are also pushing for earlier disease detection to reduce long-term treatment costs.
- •Rising prevalence of liver disorders and chronic diseases globally
- •Increasing preference for non-invasive diagnostic procedures over biopsies
- •Technological advancements improving accuracy and workflow integration
Segmentation and Regional Analysis
The market is segmented by modality into ultrasound-based and MRI-based elastography, with ultrasound currently dominating due to lower cost and broader availability. Geographically, North America and Europe lead the market, supported by advanced healthcare infrastructure and high disease awareness. The Asia-Pacific region is expected to grow fastest, driven by improving medical facilities and a large patient population.
- •North America holds the largest market share due to advanced healthcare infrastructure
- •Asia-Pacific is the fastest-growing region, driven by rising healthcare access and disease burden
- •Ultrasound elastography commands the larger share compared to MRI elastography
Trends and Outlook
What are the recent trends and outlook?
The integration of artificial intelligence and machine learning for automated elastography analysis is a major emerging trend, improving reproducibility and reducing operator dependency. Point-of-care elastography devices are gaining traction, especially in primary care and hepatology clinics. The market is expected to maintain steady growth through 2030 as clinical evidence supporting elastography expands into new therapeutic areas.
- •AI-powered software is increasingly embedded in elastography systems for faster, more consistent results
- •Miniaturized and portable elastography devices are expanding use in outpatient and primary care settings
- •Expanding clinical validation for applications beyond liver disease, including breast and thyroid imaging
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.